•  

Life Sciences

Acclerys, Inc. v. Supratek Pharma, Inc.
We represented Supratek Pharma, an innovator pharmaceutical company in Montreal, Canada, in a software licensing dispute brought by Accelrys (formerly known as Molecular Simulations, Inc.) in the U.S. District Court for the Southern District of California; Supratek had bought a license for software intended to model molecular interactions for use in drug development. Read More
Anthem Ventures v. Chiron
Defended Chiron against claims for $100 million regarding investments in a start-up company producing an inhalable antibiotic that would compete directly with Chiron's product.  We won the case on an Anti-SLAPP motion. Read More
Beckman Research Institute v. Genentech
We represented Genentech in an arbitration proceeding concerning the royalties due the plaintiff under a research and license agreement regarding recombinant DNA technology, which resulted in the issuance of two patents and the development and commercialization of two highly successful anti-cancer drugs. Read More
California Institute for Regenerative Medicine
We provided pro bono assistance to CIRM, including seconding one of our associates to work in its offices. Read More
Chiron v. Hoffman-LaRoche
We represented Chiron Corporation (now Novartis) as a plaintiff in this patent infringement action in the Northern District of California. The case involved the patent for a vaccine for the Hepatitis C virus, as well as antitrust counterclaims. Read More
Chiron v. SourceCF
Served as local counsel and then lead trial counsel representing the Chiron Corporation in a patent trial in the Northern District of California involving a Chiron drug-device combination patent. A permanent injunction was entered against the defendants. Read More
Contaminated Food Product
We are pursuing insurance coverage for numerous infant death and injury claims allegedly resulting from exposure to a contaminated food product. Read More
Cordis v. Guidant

One of our partners served on the arbitration panel that resolved patent infringement claims between Cordis Corporation and Guidant Corporation involving the groundbreaking Palmaz stent patent. The arbitration resolved claims seeking hundreds of millions of dollars in damages. Read More

Curon Medical v. Woodruff-Sawyer
We obtain a sizable jury verdict for our client in this insurance broker malpractice case arising from the insurer's denial of coverage for a personal injury claim. Read More
Gen-Probe v. Chiron
Obtained a favorable settlement for Chiron in this case asserting cross-claims about the rights of the parties under their collaboration agreement regarding the nucleic acid testing of blood. Read More
Insurance Funding / Consumer Class Action
We obtained insurance funding for the defense and settlement of a consumer class action alleging improper debt collection practices for one of our life sciences clients. Read More
Internal Employee Health Investigations
We conducted a very sensitive and confidential employee health investigation for a major life sciences company that resolved significant and widespread concerns over employee exposure to toxic materials. The investigation and our recommended plan of action successfully resolved the controversy. Read More
International Biotech Company
We represent our client in connection with a potential data breach by a former employee. Read More
International Pharmaceutical Company
We are Northern California counsel and part of the national trial team defending against claims of defects in our client’s bisphosphonate intravenous infusion products.  Read More
Ischemia Research and Educational Foundation v Pfizer, Inc., et al.

We defended Pfizer, Inc. against claims of trade secret misappropriation in Santa Clara County Superior Court.  The plaintiffs’ misappropriation claims arise out of clinical drug trials for Bextra, a second generation COX-2 inhibitor. Read More

Medical Device Company / Defamation Claims
We are assisting a medical device company to obtain the maximum coverage available under its employment practices liability policy for the defense of employment-related defamation claims asserted by the company's former CEO. Read More
Medical Device Manufacturer
We represent a medical device manufacturer to obtain insurer funding of settlements of more than 1,500 individual personal injury claims. Read More
Miotox v. Allergan
We represent the inventor and patent holder for using Botox (botulinum toxin) to treat migraine headaches, in a suit concerning the scope of royalties for follow-on (improvement) patents. Read More
Novartis v. MedImmune, Biogen, Alexion
Served as co-counsel in litigation alleging infringement of patents for a vector for the expression of polypeptides. The cases were resolved by favorable settlements for Novartis.  Read More
Pharmaceutical Company
We represent a major pharmaceutical company in presenting a claim for losses arising out of damaged pharmaceutical products under London-based stock-throughput policies, and negotiated a substantial recovery. Read More
Pharmaceutical Company Internal Investigation
We conducted an internal investigation for major pharmaceutical company in response to allegations of off-label marketing. Read More
Scottsdale Insurance v Coapt Systems, Inc., et al.
We represented the officers, directors and advisory board members of Coapt Systems in a lawsuit seeking coverage under a directors' and officers liability policy for over 60 lawsuits arising out of clinical trial studies and off-label use of bioabsorbable implants for the fixation of soft tissue in the plastic and reconstructive surgery markets.  We won a summary adjudication that the insurer had a duty to advance defense costs despite an exclusion for bodily injury claims, because the claimants also alleged fraudulent transfers by individual directors and officers. Read More
Silicon Breast Implant Cases
As lead California counsel to a Fortune 100 company in consumer/product defect silicon breast implant cases, we obtained summary judgment in more than 700+ cases under the bulk distributor/component supplier doctrines, and successfully defended related product claims including those involving the dual capacity exception to exclusive remedy doctrine. Read More
Verinata v. Sequenom
Our biotech client was subpoenaed to produce documents related to the licensing agreement between Verinata and Sequenom.  This was a very delicate matter, as there were sensitive trade secrets on both sides that had to be negotiated. Read More